Loading...
XLON
PRU
Market cap30bUSD
Jun 11, Last price  
898.80GBP
1D
0.66%
1Q
18.23%
Jan 2017
-34.29%
Name

Prudential PLC

Chart & Performance

D1W1MN
P/E
1,378.48
P/S
387.01
EPS
0.88
Div Yield, %
2.38%
Shrs. gr., 5y
16.03%
Rev. gr., 5y
-38.66%
Revenues
8.14b
-32.01%
70,763,645,12368,633,059,69765,185,919,682077,775,981,11373,536,856,40256,679,294,49789,649,488,53486,168,230,46393,564,001,99261,193,499,16288,345,465,761116,980,418,12531,635,113,18693,736,000,00057,948,000,00026,500,000,000-8,219,000,00011,970,000,0008,139,000,000
Net income
2.29b
+34.33%
1,287,081,0101,712,348,8951,878,036,68801,093,090,5682,208,606,0002,313,377,2203,550,362,7932,219,547,1853,449,134,6033,820,797,3452,370,141,8873,229,860,6703,819,409,197783,000,0002,118,000,0002,214,000,000998,000,0001,701,000,0002,285,000,000
CFO
3.61b
+333.77%
03,910,581,6891,899,851,2641,417,546,531174,635,7713,006,544,0172,698,422,556720,738,1912,183,269,2972,845,224,7543,752,648,1872,715,607,6492,189,277,9433,126,586,133-735,000,0001,966,000,000278,000,0001,078,000,000832,000,0003,609,000,000
Dividend
Sep 05, 20246.84 GBP/sh
Earnings
Aug 26, 2025

Profile

Prudential plc, through its subsidiaries, provides life and health insurance, and retirement and asset management solutions to individuals in Asia, and Africa. It offers health and protection, as well as savings products, such as participating, linked, and other traditional products. The company also provides insurance against common critical illnesses, including cancer, stroke, and heart attack; and tropical disease protection, such as dengue, malaria, and measles. It manages assets across equity, fixed income, multi asset, quantitative, and alternative strategies on behalf of institutional and individual investors. Prudential plc provides its products and services through agency sales force, banks, and brokers. The company was founded in 1848 and is headquartered in London, the United Kingdom.
URL
https://www.prudentialplc.com/
IPO date
Dec 29, 1978
Employees
14,671
Domiciled in
GB
Incorporated in
GB

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
8,139,000
-32.01%
11,970,000
-245.64%
(8,219,000)
-131.02%
Cost of revenue
3,100,000
Unusual Expense (Income)
NOPBT
8,139,000
11,970,000
(11,319,000)
NOPBT Margin
100.00%
100.00%
137.72%
Operating Taxes
538,000
385,000
454,000
Tax Rate
6.61%
3.22%
NOPAT
7,601,000
11,585,000
(11,773,000)
Net income
2,285,000
34.33%
1,701,000
70.44%
998,000
-54.92%
Dividends
(552,000)
(533,000)
(474,000)
Dividend yield
2.55%
4.37%
3.07%
Proceeds from repurchase of equity
(860,000)
4,000
(4,000)
BB yield
3.97%
-0.03%
0.03%
Debt
Debt current
527,000
699,000
501,000
Long-term debt
4,452,000
4,409,000
4,874,000
Deferred revenue
Other long-term liabilities
(5,709,000)
(5,425,000)
(3,946,000)
Net debt
(155,079,000)
(148,094,000)
(137,291,000)
Cash flow
Cash from operating activities
3,609,000
832,000
1,078,000
CAPEX
(101,000)
(44,000)
(34,000)
Cash from investing activities
(832,000)
(360,000)
(39,000)
Cash from financing activities
(1,695,000)
(1,210,000)
(2,520,000)
FCF
7,558,000
26,971,000
(11,674,000)
Balance
Cash
2,445,000
1,590,000
5,514,000
Long term investments
157,613,000
151,612,000
137,152,000
Excess cash
159,651,050
152,603,500
143,076,950
Stockholders' equity
13,264,000
12,271,000
12,121,000
Invested Capital
167,625,000
161,244,000
147,741,000
ROIC
4.62%
7.50%
ROCE
4.46%
6.85%
EV
Common stock shares outstanding
2,720,000
1,373,500
1,368,000
Price
7.97
-10.17%
8.87
-21.31%
11.28
-34.50%
Market cap
21,678,400
77.90%
12,185,692
-21.00%
15,424,200
-31.81%
EV
(132,218,600)
(135,748,308)
(121,699,800)
EBITDA
8,139,000
11,970,000
(10,349,000)
EV/EBITDA
11.76
Interest
171,000
172,000
200,000
Interest/NOPBT
2.10%
1.44%